Results 101 to 110 of about 86,125 (112)

Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

Journal of Clinical Oncology, 2005
Alex Sparreboom, William D Figg
exaly  

Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription

Journal of Bone and Mineral Research, 2011
Ha-Neui Kim, Jong-Ho Lee, Suk-Chul Bae
exaly  

Complete genome sequence of Bacillus sp. 275, producing extracellular cellulolytic, xylanolytic and ligninolytic enzymes

Journal of Biotechnology, 2017
Gyeongtaek Gong, Seil Kim, Sun-Mi Lee
exaly  

Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor

Cancer Chemotherapy and Pharmacology, 2005
Alex Sparreboom, William D Figg
exaly  

MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice

European Journal of Pharmacology, 2012
Jong-Ho Lee, Won Jong Jin, Hyunil Ha
exaly  

Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo

European Journal of Pharmacology, 2015
vijay kanth, Nagaraj M Kulkarni
exaly  

Oral Administration of Histone Deacetylase Inhibitor MS-275 Ameliorates Neuroinflammation and Cerebral Amyloidosis and Improves Behavior in a Mouse Model

Journal of Neuropathology and Experimental Neurology, 2013
Zhi-Yuan Zhang
exaly  

Novel Antimicrobial Indolepyrazines A and B from the Marine-Associated Acinetobacter sp. ZZ1275

Marine Drugs, 2019
Komal Anjum, Guowan Zheng, Zhizhen Zhang
exaly  

The Histone Deacetylase Inhibitors MS-275 and SAHA Suppress the p38 Mitogen-Activated Protein Kinase Signaling Pathway and Chemotaxis in Rheumatoid Arthritic Synovial Fibroblastic E11 Cells

Molecules, 2013
Yoshiya Tanaka, Hai-Shu Lin, Paul C Ho
exaly  

miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells

International Immunopharmacology, 2016
Mario Venza, Maria Visalli, Concetta Beninati   +2 more
exaly